US aid program sending Norplant contraceptive to Third World despite health concerns
October 12, 2012
The US Agency of International Development (AID) has announced plans to provide the the long-term Norplant contraceptive to women in developing countries.
Norplant is not distributed in advanced countries, primarily because of complaints that users developed health problems. Nearly two-thirds of women using the implanted contraceptive reported bleeding, and Norplant marketing was discontinued in the US after a series of lawsuits against the manufacturer.
AID is distributing Jadelle, a second-generation form of Norplant. Jadelle was approved for use in the US in 1996, but has not been introduced to the American market because of concerns about side effects.
For all current news, visit our News home page.
Further information:
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a current donor, log in to see the comment form; otherwise please support our work, and Sound Off!
